Dissolved and financials
CVR: 43030493
DKK 5,390
Revenue
Net result: DKK -19,190
No owners listed
CVR · view owners
No current management
CVR · view management
Dissolved
Ceased 15 September 2025
CVR · view overview
1 employee
CVR · 2022
Director role ended: Lars Larsen
CVR · 13/08/2025
View the full event history
AUKI Pharma ApS was a Danish company of the type Anpartsselskab based in Juelsminde, founded in 2022. The company has been dissolved on 15 September 2025. The company was registered under the industry Fremstilling af andre fødevarer i.a.n.. The company has 1 employee (2022). In 2023, the company reported revenue of DKK 5,390 and a net result of DKK -19,190 compared with DKK -36,750 the year before. Equity in the 2023 report amounted to DKK -15,931.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202301/01/2023 – 31/12/2023 | 5K | -19K | 1.7M | -16K | - | |
| 202201/02/2022 – 31/12/2022 | - | -37K | 1.7M | 3K | 0 |
Compared to 165 companies in Fremstilling af andre fødevarer i.a.n.
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationNo. AUKI Pharma ApS is registered in the Danish CVR register with the status Dissolved and ceased on 15 September 2025.
The CVR number of AUKI Pharma ApS is 43030493.
In 2023, AUKI Pharma ApS reported revenue of DKK 5,390.
AUKI Pharma ApS had 1 employee in 2022 according to the Danish CVR register.
AUKI Pharma ApS was founded on 1 February 2022.
AUKI Pharma ApS was registered under the industry Fremstilling af andre fødevarer i.a.n. (industry code 108900).
AUKI Pharma ApS was dissolved on September 15, 2025.
As of August 13, 2025, Lars Larsen has stepped down as director of AUKI Pharma ApS.
AUKI Pharma ApS has published its annual report for 2023. Revenue came to DKK 5,390, and the net result was DKK -19,190.
As of March 1, 2024, Lars Larsen is registered as director of AUKI Pharma ApS.
As of March 1, 2024, Eystein Eyðunsson Elttør has stepped down as director of AUKI Pharma ApS.
AUKI Pharma ApS has published its annual report for 2022. Gross profit came to DKK 57,015, and the net result was DKK -36,750.
As of February 1, 2022, Eystein Eyðunsson Elttør is registered as director of AUKI Pharma ApS.
AUKI Pharma ApS was founded on February 1, 2022.
Companies in the same industry and area
CVR 43098748
CVR 44166984
CVR 46045629
CVR 41792981